Please login to the form below

Crysvita

This page shows the latest Crysvita news and features for those working in and with pharma, biotech and healthcare.

NICE U-turn on Crystiva for rare bone disease

Tom Stratford, CEO, Kyowa Kirin International said: It is a major development that NICE has recommended Crysvita for routine use among children and young people with XLH in England and Wales. ... Crysvita targets this pathway by blocking the activity of

Latest news

Orphan drugs dominate UK Prix Galien shortlist, medtech debuts

Seven companies have been shortlisted for the Orphan Product Award; Amicus (Galafold), Biogen (Spinraza), Biomarin (Brineura), Eusa (Qarziba), Intercept (Ocaliva), Kyowa Kirin (Crysvita) and Shire (Revestive).
NICE set to reject Kyowa Kirin’s Crysvita for XLH

is set to receive a NICE rejection for its rare disease therapy Crysvita (burosumab). ... Crysvita’s annual pricing is conditional on the patient’s weight but has an upper estimated price of an eye watering £388, 960 a year for a 17-year-old
Rigel and Ultragenyx claim approvals for rare drugs

Tavalisse and Crysvita are set to treat patients with chronic ITP and XLH, respectively. ... Ultragenyx’s FDA approval was for Crysvita (burosumab), which has become the first approved drug for adults and children ages one year and older with X-linked

More from news
Approximately 3 fully matching, plus 1 partially matching documents found.

Featured jobs

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Account Director, Medical Education: Salary TBC

Senior Account Manager, Medical Communications, London: Excellent package

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Freelance AM/ AD Healthcare Advertising: £350-400 depending on experience

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Scientific Director – Medical Communications: Salary TBC

Senior Account Director – Healthcare Advertising – London: Salary TBC

Home-based Medical Writer – Medical Education: Salary TBC

Associate Director – Social Healthcare – London: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

AM – Corporate Comms/ Public Affairs/ B2B – Healthcare Focus: Salary TBC

Programme/ Account Director - Healthcare PR - London: Salary TBC

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Digital Account Director: Salary TBC

Account Director, Healthcare Marketing Agency: Salary TBC

Freelance Senior Account Manager / Account Director - Healthcare...: £350-400 depending on experience

Home based, Senior Medical Writer, Medical Communications: Excellent package

Creative/ Medical Writer: Circa £35, 000 With Benefits

Senior Account Executive – Account Manager – Healthcare Advertis...: £32000 - £43000 Bonus Benfits

EU Head of Business Development and Client Service: Exceptional packge and bonus

Senior Medical Writer: Salary TBC

Health Consultant - Brand Comms: Competitive Salary

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Subscribe to our email news alerts

PMHub

Add my company

Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...